Literature DB >> 35239092

Circ_0016760 Serves as a Cancer Promoter in Non-small Cell Lung Cancer Through miR-876-3p/NOVA2 Axis.

Fengjie Liu1, Haiying Gao1, Mingwei Chen2, Anqi Li2, Ting Liu3.   

Abstract

Non-small cell lung cancer (NSCLC) is a serious threaten to human health globally. Circular RNAs (circRNAs) were testified to alter the progression of NSCLC. This work intended to investigate the functional role of circ_0016760 in NSCLC development and the potential mechanism. Expression of circ_0016760, microRNA (miR)-876-3p and NOVA alternative splicing regulator 2 (NOVA2) was determined via quantitative reverse transcription-PCT (qRT-PCR) or western blotting. Cell viability, clonogenicity and apoptosis were assessed by Cell Counting Kit-8 (CCK-8) assay, colony formation assay and flow cytometry, respectively. Transwell assay was performed to examine cell migration and invasion. Western blotting was also conducted to detect the levels of epithelial-to-mesenchymal transition (EMT)-related proteins. Role of circ_0016760 in vivo was evaluated via xenograft model assay. Moreover, the interaction between miR-876-3p and circ_0016760 or NOVA2 was verified by dual-luciferase reporter assay or RNA Immunoprecipitation (RIP) assay. Circ_0016760 and NOVA2 were upregulated, while miR-876-3p expression was decreased in NSCLC tissues and cells. Circ_0016760 depletion suppressed NSCLC cell proliferation and metastasis in vitro, as well as hampered tumor growth in vivo. Circ_0016760 acted as a sponge of miR-876-3p, and miR-876-3p could target NOVA2. Circ_0016760 might play vital roles in NSCLC by regulating miR-876-3p/NOVA2 axis. Circ_0016760 could promote the malignant development of NSCLC through miR-876-3p/NOVA2 axis, at least in part.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Circ_0016760; NOVA2; Non-small cell lung cancer; miR-876-3p

Year:  2022        PMID: 35239092     DOI: 10.1007/s10528-022-10198-4

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  39 in total

Review 1.  The Biogenesis, Functions, and Challenges of Circular RNAs.

Authors:  Xiang Li; Li Yang; Ling-Ling Chen
Journal:  Mol Cell       Date:  2018-07-26       Impact factor: 17.970

2.  The biogenesis and emerging roles of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-24       Impact factor: 94.444

Review 3.  The biology and management of non-small cell lung cancer.

Authors:  Roy S Herbst; Daniel Morgensztern; Chris Boshoff
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

Review 4.  New and emerging targeted treatments in advanced non-small-cell lung cancer.

Authors:  Fred R Hirsch; Kenichi Suda; Jacinta Wiens; Paul A Bunn
Journal:  Lancet       Date:  2016-09-01       Impact factor: 79.321

5.  Circular RNA Circ_0016760 Modulates Non-Small-Cell Lung Cancer Growth Through the miR-577/ZBTB7A Axis.

Authors:  Yanhong Hao; Junfeng Xi; Yancai Peng; Burong Bian; Guangjun Hao; Yunfeng Xi; Zhibin Zhang
Journal:  Cancer Manag Res       Date:  2020-07-08       Impact factor: 3.989

Review 6.  Non-small-cell lung cancer.

Authors:  Cesare Gridelli; Antonio Rossi; David P Carbone; Juliana Guarize; Niki Karachaliou; Tony Mok; Francesco Petrella; Lorenzo Spaggiari; Rafael Rosell
Journal:  Nat Rev Dis Primers       Date:  2015-05-21       Impact factor: 52.329

7.  Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis.

Authors:  Yongsheng Li; Jiahang Hu; Lijuan Li; Shengyan Cai; Hengchun Zhang; Xianfeng Zhu; Guijie Guan; Xiangmei Dong
Journal:  Biochem Biophys Res Commun       Date:  2018-08-06       Impact factor: 3.575

8.  Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.

Authors:  Jia Cheng; Huiqin Zhuo; Mao Xu; Linpei Wang; Hao Xu; Jigui Peng; Jingjing Hou; Lingyun Lin; Jianchun Cai
Journal:  J Transl Med       Date:  2018-08-02       Impact factor: 5.531

9.  Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature.

Authors:  Stefania Gallo; Maria Vittoria Arcidiacono; Veronica Tisato; Roberta Piva; Letizia Penolazzi; Cristina Bosi; Carlo V Feo; Roberta Gafà; Paola Secchiero
Journal:  Onco Targets Ther       Date:  2018-09-20       Impact factor: 4.147

10.  Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer.

Authors:  Lijian Chen; Aruo Nan; Nan Zhang; Yangyang Jia; Xin Li; Yihui Ling; Jiabin Dai; Shaozhu Zhang; Qiaoyuan Yang; Yanni Yi; Yiguo Jiang
Journal:  Mol Cancer       Date:  2019-01-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.